Navigating healthcare costs in Southern California can often feel like a full-time job.
For millions of older adults and Medicare recipients living in L.A., prescription drug expenses add up quickly. A new federal initiative aims to bring welcome relief to your monthly budget.
According to a report by KTLA 5, the Centers for Medicare & Medicaid Services (CMS) is launching a temporary Medicare GLP-1 Bridge program.
The pilot caps out-of-pocket costs for select popular weight-loss medications at $50 per month through December 31, 2027.
Here is what you need to know about the new program, who qualifies, and which treatments are covered.
You must have a qualifying Medicare Part D plan
To take advantage of the $50 cap, participants must currently be enrolled in a qualifying Medicare Part D prescription drug plan.
Keep in mind that certain special Medicare coverage arrangements are excluded from the initiative.
There is also a key restriction: beneficiaries cannot already receive a covered GLP-1 drug through their existing Part D plan.
If your current plan already covers your prescription, Medicare advises you to stick with your existing policy.
Certain pre-existing conditions affect eligibility
Your current health diagnoses directly impact whether you can use the Bridge program.
According to CMS, patients diagnosed with Type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease may not qualify.
This is because standard Medicare Part D benefits frequently offer coverage for GLP-1 prescriptions when prescribed to treat those specific medical conditions.
Specific weight and health benchmarks apply
The program is designed specifically for individuals meeting distinct clinical criteria.
To qualify, adults generally need to have a body mass index (BMI) of at least 35.
Applicants with a lower BMI may also qualify if they live with related medical conditions, including:
- Uncontrolled high blood pressure
- Chronic kidney disease
- Prediabetes
- A history of heart attack, stroke, or peripheral artery disease
Which medications are covered under the $50 cap?
According to the National Council on Aging, the temporary demonstration covers Foundayo, Wegovy, and Zepbound KwikPen products.
Qualifying recipients pay a flat $50 monthly copayment regardless of household income for the duration of the program, which runs through late 2027.
Angelenos looking to check their coverage or apply should review their current Part D policy details on Medicare.gov or consult their prescribing physician to confirm clinical eligibility.
For more, follow us on Facebook, Instagram, TikTok, and now WhatsApp!
